您当前的位置:
首页 >
文章列表页 >
Discussion on Within-cycle Correction of Markov Model in Pharmacoeconomic Evaluation
更新时间:2022-06-21
    • Discussion on Within-cycle Correction of Markov Model in Pharmacoeconomic Evaluation

    • China Pharmacy   Vol. 31, Issue 8, (2020)
    • Published:2020

    扫 描 看 全 文

  • WO Tian, CHEN Lei, XI Xiaoyu. Discussion on Within-cycle Correction of Markov Model in Pharmacoeconomic Evaluation. [J]. China Pharmacy 31(8).(2020) DOI:

  •  
  •  

0

Views

63

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Pharmacoeconomics of ivabradine in the treatment of CHF in the context of “Quadruple Therapy”
Study on pharmacoeconomic evaluation of vericiguat in the treatment of heart failure with reduced ejection fraction
Pharmacoeconomic evaluation of sugemalimab consolidation therapy for stage Ⅲ non-small cell lung cancer
Pharmacoeconomic evaluation of serplulimab combined with chemotherapy regimens for the first-line treatment of extensive-stage small-cell lung cancer
Rapid health technology assessment of Aidi injection combined with first-line chemotherapy for non-small cell lung cancer

Related Author

CHEN Congling
WU Han
ZHOU Jie
ZHANG Ruobin
ZHANG Jinping
BAO Xue
YANG Xian
LI Feng

Related Institution

Dept. of Cardiology, Nanjing Drum Tower Hospital
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University
Dept. of Pharmacy, Nanjing Drum Tower Hospital
Dept. of Pharmacy, the Affiliated Hospital of North Medical College, Sichuan Nanchong
School of International Pharmaceutical Business, China Pharmaceutical University
0